The 55 DKTK Munich Cancer Colloquium will be held on January 31, 2022.
Talks will be given by:
Prof. Irmela Jeremias - In vivo PDX CRISPR/Cas9 screens identify BCL2 inhibition as mechanism to overcome genetically diverse chemo-resistance
Dr. med. Erik T Orberg - Longitudinal Multi-omic Analysis in Allogeneic Stem Cell Transplantation Patients identifies Microbial and Metabolomic Signatures for Acute Graft-vs-Host-Disease
Dr. rer. nat. Dr. med. Kim M Kraus - Radioimmunotherapy of lung tumors with Checkpointinhibitors – what is safe?
Agenda and Login
Meeting ID: 830 1946 9370 Kenncode: 68840493
key words: haematology, immuno therapy, radiation oncology, signaling pathways
17:30 - 19:00
DKTK partner site Munich